Pregnane X receptor (pxr) at the crossroads of human metabolism and disease

Current Drug Metabolism

Volumn 14, Issue 3, 2013, Pages 341-350

  Koutsounas, Ioannis ^a   Theocharis, Stamatios ^a   Patsouris, Efstratios ^a   Giaginis, Constantinos ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF THE AEGEAN   (Greece)

Author keywords

Bile acids; Chemotherapeutic agents; Drug resistance; Metabolism; Pregnane X Receptor; Xenobiotics

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; CARBAMAZEPINE; CLOTRIMAZOLE; CYCLOPHOSPHAMIDE; CYPROTERONE ACETATE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN; GLUTETHIMIDE; GUGGULSTERONE; HYPERICUM PERFORATUM EXTRACT; INDOMETACIN; KAVA; MIFEPRISTONE; MULTIDRUG RESISTANCE PROTEIN 1; NIFEDIPINE; NUCLEAR RECEPTOR COACTIVATOR; PACLITAXEL; PHENOBARBITAL; PREGNANE X RECEPTOR; RIFAMPICIN; RITONAVIR; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; SPIRONOLACTONE; STEROID RECEPTOR COACTIVATOR 1; TAMOXIFEN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; WARFARIN; XENOBIOTIC AGENT;

ARTICLE; BILE ACID METABOLISM; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PATIENT; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG METABOLISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; ENTERITIS; FATTY LIVER; FIBROGENESIS; GENE TARGETING; HERBAL MEDICINE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; LIGAND BINDING; LIPID METABOLISM; LIVER TOXICITY; NEOPLASM; PRIMARY BILIARY CIRRHOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; STEROID METABOLISM; TRANSCRIPTION REGULATION; TUBERCULOSIS;

ANIMALS; BONE DISEASES; FATTY LIVER; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER CIRRHOSIS; NEOPLASMS; PHARMACEUTICAL PREPARATIONS; RECEPTORS, STEROID; TRANSCRIPTION, GENETIC;

EID: 84877934154     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/1389200211314030009     Document Type: Article

References (85)

1. Hustert, E.; Zibat, A.; Presecan-Siedel, E.; Eiselt, R.; Mueller, R.; Fuss, C.; Brehm, I.; Brinkmann, U.; Eichelbaum, M.; Wojnowski, L.; Burk, O. Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. Drug Metab. Dispos., 2001, 29(11), 1454-1459. (Pubitemid 33000692)
2. Ma, X.; Idle, J.R.; Gonzalez, F.J. The pregnane X receptor: from bench to bedside. Expert Opin. Drug Metab. Toxicol., 2008, 4(7), 895-908.
3. Albermann, N.; Schmitz-Winnenthal, F.H; Z'Graggen, K.; Volk, C.; Hoffmann, M.M.; Haefeli, W.E.; Weiss, J. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem. Pharmacol., 2005, 70(6), 949-958. (Pubitemid 41138860)
4. Lamba, V.; Yasuda, K.; Lamba, J.K.; Assem, M.; Davila, J.; Strom, S.; Schuetz, E.G. PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol. Appl. Pharmacol., 2004, 199(3), 251-265. (Pubitemid 39208725)
5. Owen, A.; Chandler, B.; Back, D.J.; Khoo, S.H. Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNA. Antivir. Ther., 2004, 9(5), 819-821. (Pubitemid 39434346)
6. Dotzlaw, H.; Leygue, E.; Watson, P.; Murphy, L.C. The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin. Cancer Res., 1999, 5(8), 2103-2107. (Pubitemid 29399265)
7. Staudinger, J.L.; Goodwin, B.; Jones, S.A.; Hawkins-Brown, D.; MacKenzie, K.I.; LaTour, A.; Liu, Y.; Klaassen, C.D.; Brown, K.K.; Reinhard, J.; Willson, T.M.; Koller, B.H.; Kliewer, S.A. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. U S A, 2001, 98(6), 3369-3374. (Pubitemid 32220852)
8. Watkins, R.E.; Wisely, G.B.; Moore, L.B.; Collins, J.L.; Lambert, M.H.; Williams, S.P.; Willson, T.M.; Kliewer, S.A.; Redinbo, M.R. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science, 2001, 292(5525), 2329-2333. (Pubitemid 32568055)
9. Koyano, S.; Kurose, K.; Saito, Y.; Ozawa, S.; Hasegawa, R.; Komamura, K.; Ueno, K.; Kamakura, S.; Kitakaze, M.; Nakajima, T.; Matsumoto, K.; Akasawa, A.; Saito, H.; Sawada, J. Functional characterization of four naturally occurring variants of human pregnane X receptor (PXR): one variant causes dramatic loss of both DNA binding activity and the transactivation of the CYP3A4 promoter/enhancer region. Drug Metab. Dispos., 2004, 32(1), 149-154. (Pubitemid 38112547)
10. Zhang, J.; Kuehl, P.; Green, E.D.; Touchman, J.W.; Watkins, P.B.; Daly, A.; Hall, S.D.; Maurel, P.; Relling, M.; Brimer, C.; Yasuda, K.; Wrighton, S.A.; Hancock, M.; Kim, R.B.; Strom, S.; Thummel, K.; Russell, C.G.; Hudson, J.R., Jr.; Schuetz, E.G.; Boguski, M.S. The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics, 2001, 11(7), 555-572. (Pubitemid 32953582)
11. Watkins, R.E.; Davis-Searles, P.R.; Lambert, M.H.; Redinbo, M.R. Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. J. Mol. Biol., 2003, 331(4), 815-828. (Pubitemid 36945439)
12. Kawana, K.; Ikuta, T.; Kobayashi, Y.; Gotoh, O.; Takeda, K.; Kawajiri, K. Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR. Mol. Pharmacol., 2003, 63(3), 524-531. (Pubitemid 36297321)
13. Pascussi, J.M.; Drocourt, L.; Fabre, J.M.; Maurel, P.; Vilarem, M.J. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol. Pharmacol., 2000, 58(2), 361-372. (Pubitemid 30497480)
14. Synold, T.W.; Dussault, I.; Forman, B.M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med., 2001, 7(5), 584-590. (Pubitemid 32448326)
15. Bertilsson, G.; Heidrich, J.; Svensson, K.; Asman, M.; Jendeberg, L.; Sydow-Backman, M.; Ohlsson, R.; Postlind, H.; Blomquist, P.; Berkenstam, A. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc. Natl. Acad. Sci. U S A, 1998, 95(21), 12208-12213. (Pubitemid 28483744)
16. Honkakoski, P.; Sueyoshi, T.; Negishi, M. Drug-activated nuclear receptors CAR and PXR. Ann. Med., 2003, 35(3), 172-182. (Pubitemid 36765230)
17. Persson, K.P.; Ekehed, S.; Otter, C.; Lutz, E.S.; McPheat, J.; Masimirembwa, C.M.; Andersson, T.B. Evaluation of human liver slices and reporter gene assays as systems for predicting the cytochrome p450 induction potential of drugs in vivo in humans. Pharm. Res., 2006, 23(1), 56-69. (Pubitemid 43214661)
18. Giessmann, T.; May, K.; Modess, C.; Wegner, D.; Hecker, U.; Zschiesche, M.; Dazert, P.; Grube, M.; Schroeder, E.; Warzok, R.; Cascorbi, I.; Kroemer, H.K.; Siegmund, W. Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans. Clin. Pharmacol. Ther., 2004, 76(3), 192-200. (Pubitemid 39221793)
19. Staudinger, J.L.; Ding, X.; Lichti, K. Pregnane X receptor and natural products: beyond drug-drug interactions. Expert Opin. Drug Metab. Toxicol., 2006, 2(6), 847-857. (Pubitemid 44911536)
20. Tabb, M.M.; Sun, A.; Zhou, C.; Grun, F.; Errandi, J.; Romero, K.; Pham, H.; Inoue, S.; Mallick, S.; Lin, M.; Forman, B.M.; Blumberg, B. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J. Biol. Chem., 2003, 278(45), 43919-43927. (Pubitemid 37377131)
21. Lemaire, G.; Mnif, W.; Pascussi, J.M.; Pillon, A.; Rabenoelina, F.; Fenet, H.; Gomez, E.; Casellas, C.; Nicolas, J.C.; Cavailles, V.; Duchesne, M.J.; Balaguer, P. Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system. Toxicol. Sci., 2006, 91(2), 501-509. (Pubitemid 43832507)
22. di Masi, A.; De Marinis, E.; Ascenzi, P.; Marino, M. Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. Mol. Aspects Med., 2009, 30(5), 297-343.
23. Huang, H.; Wang, H.; Sinz, M.; Zoeckler, M.; Staudinger, J.; Redinbo, M.R.; Teotico, D.G.; Locker, J.; Kalpana, G.V.; Mani, S. Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole. Oncogene, 2007, 26(2), 258-268. (Pubitemid 46095736)
24. Zhou, C.; Poulton, E.J.; Grun, F.; Bammler, T.K.; Blumberg, B.; Thummel, K.E.; Eaton, D.L. The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol. Pharmacol., 2007, 71(1), 220-229. (Pubitemid 46020992)
25. Wang, H.; Li, H.; Moore, L.B.; Johnson, M.D.; Maglich, J.M.; Goodwin, B.; Ittoop, O.R.; Wisely, B.; Creech, K.; Parks, D.J.; Collins, J.L.; Willson, T.M.; Kalpana, G.V.; Venkatesh, M.; Xie, W.; Cho, S.Y.; Roboz, J.; Redinbo, M.; Moore, J.T.; Mani, S. The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptor. Mol. Endocrinol., 2008, 22(4), 838-857. (Pubitemid 351482821)
26. Jones, S.A.; Moore, L.B.; Shenk, J.L.; Wisely, G.B.; Hamilton, G.A.; McKee, D.D.; Tomkinson, N.C.; LeCluyse, E.L.; Lambert, M.H.; Willson, T.M.; Kliewer, S.A.; Moore, J.T. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol. Endocrinol., 2000, 14(1), 27-39. (Pubitemid 32260325)
27. Nguyen, A.; Bouscarel, B. Bile acids and signal transduction: role in glucose homeostasis. Cell. Signal., 2008, 20(12), 2180-2197.
28. Bachs, L.; Pares, A.; Elena, M.; Piera, C.; Rodes, J. Effects of longterm rifampicin administration in primary biliary cirrhosis. Gastroenterology, 1992, 102(6), 2077-2080.
29. Prince, M.I.; Burt, A.D.; Jones, D.E. Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis. Gut, 2002, 50(3), 436-439. (Pubitemid 34161065)
30. He, J.; Nishida, S.; Xu, M.; Makishima, M.; Xie, W. PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. Gastroenterology, 2011, 140(7), 2095-2106.
31. Dussault, I.; Yoo, H.D.; Lin, M.; Wang, E.; Fan, M.; Batta, A.K.; Salen, G.; Erickson, S.K.; Forman, B.M. Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proc. Natl. Acad. Sci. U S A, 2003, 100(3), 833-888
32. Zhou, J.; Zhai, Y.; Mu, Y.; Gong, H.; Uppal, H.; Toma, D.; Ren, S.; Evans, R.M.; Xie, W. A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. J. Biol. Chem., 2006, 281(21), 15013-15020. (Pubitemid 43855205)
33. Roth, A.; Looser, R.; Kaufmann, M.; Blattler, S.M.; Rencurel, F.; Huang, W.; Moore, D.D.; Meyer, U.A. Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression. Mol. Pharmacol., 2008, 73(4), 1282-1289. (Pubitemid 351439210)
34. Bachmann, K.; Patel, H.; Batayneh, Z.; Slama, J.; White, D.; Posey, J.; Ekins, S.; Gold, D.; Sambucetti, L. PXR and the regulation of apoA1 and HDL-cholesterol in rodents. Pharmacol. Res., 2004, 50(3), 237-246. (Pubitemid 38844476)
35. Lutjohann, D.; Hahn, C.; Prange, W.; Sudhop, T.; Axelson, M.; Sauerbruch, T.; von Bergmann, K.; Reichel, C. Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men. Int. J. Clin. Pharmacol. Ther., 2004, 42(6), 307-313. (Pubitemid 38787274)
36. Barbaro, G. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection. Curr. HIV Res., 2006, 4(1), 79-85.
37. Zhai, Y.; Pai, H.V.; Zhou, J.; Amico, J.A.; Vollmer, R.R.; Xie, W. Activation of pregnane X receptor disrupts glucocorticoid and mineralocorticoid homeostasis. Mol. Endocrinol., 2007, 21(1), 138-147. (Pubitemid 46041695)
38. Buters, J.T.; Korzekwa, K.R.; Kunze, K.L.; Omata, Y.; Hardwick, J.P.; Gonzalez, F.J. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Drug Metab. Dispos., 1994, 22(5), 688-692. (Pubitemid 24307481)
39. Konishi, H.; Tanaka, K.; Minouchi, T.; Yamaji, A. Urinary 6betahydroxycortisol/17-hydroxycorticosteroids ratio as a measure of hepatic CYP3A4 capacity after enzyme induction. Ann. Clin. Biochem., 2004, 41, 335-337. (Pubitemid 38954884)
40. Badawi, A.F.; Cavalieri, E.L.; Rogan, E.G. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alphahydroxylation of 17beta-estradiol. Metabolism, 2001, 50(9), 1001-1003. (Pubitemid 32904154)
41. Yu, A.M.; Fukamachi, K.; Krausz, K.W.; Cheung, C.; Gonzalez, F.J. Potential role for human cytochrome P450 3A4 in estradiol homeostasis. Endocrinology, 2005, 146(7), 2911-2919. (Pubitemid 41002798)
42. Konno, Y.; Negishi, M.; Kodama, S. The roles of nuclear receptors CAR and PXR in hepatic energy metabolism. Drug Metab. Pharmacokinet., 2008, 23(1), 8-13.
43. Quattrochi, L.C.; Guzelian, P.S. Cyp3A regulation: from pharmacology to nuclear receptors. Drug Metab. Dispos., 2001, 29(5), 615-622. (Pubitemid 32374560)
44. Rosenfeld, J.M.; Vargas, R., Jr.; Xie, W.; Evans, R.M. Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol. Endocrinol., 2003, 17(7), 1268-1282. (Pubitemid 36819950)
45. Matic, M.; Mahns, A.; Tsoli, M.; Corradin, A.; Polly, P.; Robertson, G.R. Pregnane X receptor: promiscuous regulator of detoxification pathways. Int. J. Biochem. Cell Biol., 2007, 39(3), 478-483. (Pubitemid 46096787)
46. Chen, T. Overcoming drug resistance by regulating nuclear receptors. Adv. Drug Deliv. Rev., 2010, 62(13), 1257-1264.
47. Cerveny, L.; Svecova, L.; Anzenbacherova, E.; Vrzal, R.; Staud, F.; Dvorak, Z.; Ulrichova, J.; Anzenbacher, P.; Pavek, P. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab. Dispos., 2007, 35(7), 1032-1041. (Pubitemid 46956421)
48. Niemi, M.; Backman, J.T.; Fromm, M.F.; Neuvonen, P.J.; Kivisto, K.T. Pharmacokinetic interactions with rifampicin : clinical relevance. Clin. Pharmacokinet., 2003, 42(9), 819-850. (Pubitemid 36995083)
49. Backman, J.T.; Olkkola, K.T.; Neuvonen, P.J. Rifampin drastically reduces plasma concentrations and effects of oral midazolam. Clin. Pharmacol. Ther., 1996, 59(1), 7-13. (Pubitemid 26046768)
50. Ivanovic, J.; Nicastri, E.; Ascenzi, P.; Bellagamba, R.; De Marinis, E.; Notari, S.; Pucillo, L.P.; Tozzi, V.; Ippolito, G.; Narciso, P. Therapeutic drug monitoring in the management of HIV-infected patients. Curr. Med. Chem., 2008, 15(19), 1925-1939.
51. Gaster, B.; Holroyd, J. St John's wort for depression: a systematic review. Arch. Intern. Med., 2000, 160(2), 152-156. (Pubitemid 30054333)
52. Wentworth, J.M.; Agostini, M.; Love, J.; Schwabe, J.W.; Chatterjee, V.K. St John's wort, a herbal antidepressant, activates the steroid X receptor. J. Endocrinol., 2000, 166(3), R11-16.
53. Ruschitzka, F.; Meier, P.J.; Turina, M.; Luscher, T.F.; Noll, G. Acute heart transplant rejection due to Saint John's wort. Lancet, 2000, 355(9203), 548-549. (Pubitemid 30088678)
54. Pascussi, J.M.; Robert, A.; Nguyen, M.; Walrant-Debray, O.; Garabedian, M.; Martin, P.; Pineau, T.; Saric, J.; Navarro, F.; Maurel, P.; Vilarem, M.J. Possible involvement of pregnane X receptorenhanced CYP24 expression in drug-induced osteomalacia. J. Clin. Invest., 2005, 115(1), 177-186. (Pubitemid 40385519)
55. Xu, Y.; Hashizume, T.; Shuhart, M.C.; Davis, C.L.; Nelson, W.L.; Sakaki, T.; Kalhorn, T.F.; Watkins, P.B.; Schuetz, E.G.; Thummel, K.E. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. Mol. Pharmacol., 2006, 69(1), 56-65. (Pubitemid 43048893)
56. Igarashi, M.; Yogiashi, Y.; Mihara, M.; Takada, I.; Kitagawa, H.; Kato, S. Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene. Mol. Cell. Biol., 2007, 27(22), 7947-7954. (Pubitemid 350086427)
57. Zhou, C.; Verma, S.; Blumberg, B. The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nucl. Recept. Signal., 2009, 7, e001.
58. Lee, J.H.; Zhou, J.; Xie, W. PXR and LXR in hepatic steatosis: a new dog and an old dog with new tricks. Mol. Pharm., 2008, 5(1), 60-66. (Pubitemid 351300035)
59. Dai, G.; He, L.; Bu, P.; Wan, Y.J. Pregnane X receptor is essential for normal progression of liver regeneration. Hepatology, 2008, 47(4), 1277-1287. (Pubitemid 351547914)
60. Piriou, A.; Maissiat, R.; Jacqueson, A.; Warnet, J.M.; Claude, J.R. Ultrastructural changes in the parenchymal liver cells of rats treated with high doses of rifampicin. Br. J. Exp. Pathol., 1987, 68(2), 201-207. (Pubitemid 17051486)
61. Sookoian, S.; Castano, G.O.; Burgueno, A.L.; Gianotti, T.F.; Rosselli, M.S.; Pirola, C.J. The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease. Pharmacogenet. Genomics, 2010, 20(1), 1-8.
62. Langmann, T.; Moehle, C.; Mauerer, R.; Scharl, M.; Liebisch, G.; Zahn, A.; Stremmel, W.; Schmitz, G. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology, 2004, 127(1), 26-40. (Pubitemid 38962271)
63. Martinez, A.; Marquez, A.; Mendoza, J.; Taxonera, C.; Fernandez-Arquero, M.; Diaz-Rubio, M.; De La Concha, E.G.; Urcelay, E. Role of the PXR gene locus in inflammatory bowel diseases. Inflamm. Bowel Dis., 2007, 13(12), 1484-1487.
64. Shah, Y.M.; Ma, X.; Morimura, K.; Kim, I.; Gonzalez, F.J. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 292(4), G1114-1122. (Pubitemid 46557773)
65. Chen, C.; Shah, Y.M.; Morimura, K.; Krausz, K.W.; Miyazaki, M.; Richardson, T.A.; Morgan, E.T.; Ntambi, J.M.; Idle, J.R.; Gonzalez, F.J. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell. Metab., 2008, 7(2), 135-147. (Pubitemid 351168558)
66. Maier, A.; Zimmermann, C.; Beglinger, C.; Drewe, J.; Gutmann, H. Effects of budesonide on P-glycoprotein expression in intestinal cell lines. Br. J. Pharmacol., 2007, 150(3), 361-368. (Pubitemid 46221044)
67. Guslandi, M.; Petrone, M.C.; Testoni, P.A. Rifaximin for active ulcerative colitis. Inflamm. Bowel Dis., 2006, 12(4), 335.
68. Ma, X.; Shah, Y.M.; Guo, G.L.; Wang, T.; Krausz, K.W.; Idle, J.R.; Gonzalez, F.J. Rifaximin is a gut-specific human pregnane X receptor activator. J. Pharmacol. Exp. Ther., 2007, 322(1), 391-398. (Pubitemid 46956365)
69. Wahli, W. A gut feeling of the PXR, PPAR and NF-kappaB connection. J. Intern. Med., 2008, 263(6), 613-619. (Pubitemid 351678588)
70. Marek, C.J.; Tucker, S.J.; Konstantinou, D.K.; Elrick, L.J.; Haefner, D.; Sigalas, C.; Murray, G.I.; Goodwin, B.; Wright, M.C. Pregnenolone-16alpha- carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXRindependent mechanisms. Biochem. J., 2005, 387(Pt 3), 601-608. (Pubitemid 40685693)
71. Haughton, E.L.; Tucker, S.J.; Marek, C.J.; Durward, E.; Leel, V.; Bascal, Z.; Monaghan, T.; Koruth, M.; Collie-Duguid, E.; Mann, D.A.; Trim, J.E.; Wright, M.C. Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro. Gastroenterology, 2006, 131(1), 194-209. (Pubitemid 44015746)
72. Hanada, K.; Nakai, K.; Tanaka, H.; Suzuki, F.; Kumada, H.; Ohno, Y.; Ozawa, S.; Ogata, H. Effect of nuclear receptor downregulation on hepatic expression of cytochrome p450 and transporters in chronic hepatitis c in association with fibrosis development. Drug Metab. Pharmacokinet., 2012, 27(3), 301-306.
73. Desai, P.B.; Nallani, S.C.; Sane, R.S.; Moore, L.B.; Goodwin, B.J.; Buckley, D.J.; Buckley, A.R. Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen. Drug Metab. Dispos., 2002, 30(5), 608-612. (Pubitemid 34456986)
74. Mani, S.; Huang, H.; Sundarababu, S.; Liu, W.; Kalpana, G.; Smith, A.B.; Horwitz, S.B. Activation of the steroid and xenobiotic receptor (human pregnane X receptor) by nontaxane microtubulestabilizing agents. Clin. Cancer Res., 2005, 11(17), 6359-6369. (Pubitemid 41262968)
75. Huang, R.; Murry, D.J.; Kolwankar, D.; Hall, S.D.; Foster, D.R. Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines. Biochem. Pharmacol., 2006, 71(12), 1695-1704.
76. Chen, Y.; Tang, Y.; Wang, M.T.; Zeng, S.; Nie, D. Human pregnane X receptor and resistance to chemotherapy in prostate cancer. Cancer Res., 2007, 67(21), 10361-10367. (Pubitemid 350070811)
77. Masuyama, H.; Nakatsukasa, H.; Takamoto, N.; Hiramatsu, Y. Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells. Mol. Pharmacol., 2007, 72(4), 1045-1053. (Pubitemid 47481427)
78. Mensah-Osman, E.J.; Thomas, D.G.; Tabb, M.M.; Larios, J.M.; Hughes, D.P.; Giordano, T.J.; Lizyness, M.L.; Rae, J.M.; Blumberg, B.; Hollenberg, P.F.; Baker, L.H. Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines. Cancer, 2007, 109(5), 957-965. (Pubitemid 46333537)
79. Zelunka, E.J. Intravenous cyclosporine-rifampin interaction in a pediatric bone marrow transplant recipient. Pharmacotherapy, 2002, 22(3), 387-390. (Pubitemid 34205176)
80. Murry, D.J.; Cherrick, I.; Salama, V.; Berg, S.; Bernstein, M.; Kuttesch, N.; Blaney, S.M. Influence of phenytoin on the disposition of irinotecan: a case report. J. Pediatr. Hematol. Oncol., 2002, 24(2), 130-133. (Pubitemid 34150553)
81. Chang, S.M.; Kuhn, J.G.; Rizzo, J.; Robins, H.I.; Schold, S.C., Jr.; Spence, A.M.; Berger, M.S.; Mehta, M.P.; Bozik, M.E.; Pollack, I.; Gilbert, M.; Fulton, D.; Rankin, C.; Malec, M.; Prados, M.D. Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J. Clin. Oncol., 1998, 16(6), 2188-2194. (Pubitemid 28265057)
82. Zamboni, W.C.; Gajjar, A.J.; Heideman, R.L.; Beijnen, J.H.; Rosing, H.; Houghton, P.J.; Stewart, C.F. Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma. Clin. Cancer Res., 1998, 4(3), 783-789. (Pubitemid 28193579)
83. Druker, B.J.; Talpaz, M.; Resta, D.J.; Peng, B.; Buchdunger, E.; Ford, J.M.; Lydon, N.B.; Kantarjian, H.; Capdeville, R.; Ohno-Jones, S.; Sawyers, C.L. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med., 2001, 344(14), 1031-1037. (Pubitemid 32267972)
84. Dowsett, M.; Cuzick, J.; Howell, A.; Jackson, I. Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial. Br. J. Cancer, 2001, 85(3), 317-324. (Pubitemid 32747695)
85. Chang, T.K.; Yu, L.; Maurel, P.; Waxman, D.J. Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines. Cancer Res., 1997, 57(10), 1946-1954. (Pubitemid 27209726)